Skip to main content
    P

    Pmv Pharmaceuticals Inc (PMVP)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $1.22
    +0.03 (+2.52%)

    Market Cap: $89.89M

    Last updated: Nov 17, 2026 at 4:10 PM ET

    Pmv Pharmaceuticals Inc (PMVP) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    Pmv Pharmaceuticals (PMVP) has a market cap of $89.89M and an enterprise value of $69.89M. Its share count is up 24.98% from a year earlier. It holds $19.99M more cash than debt, 22.24% of its market cap.

    Total Valuation

    Enterprise value is 22.24% below the market cap, as cash exceeds debt.

    Market Cap$89.89M
    Enterprise Value$69.89M
    Latest price (Nov 17, 2026)$1.22

    Key Dates

    The next earnings report is expected on Mar 4, 2027, covering the quarter ending Dec 31, 2026.

    Next Earnings DateMar 4, 2027 (expected)
    Last Earnings DateNov 10, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count rose 24.06% in the quarter ended Sep 30, 2026 and grew 13.32% a year over 2 years.

    Shares Outstanding66.23M
    Shares Change (YoY)+24.98%
    Shares Change (QoQ)+24.06%
    Share Count Growth (2Y CAGR)+13.32%

    Price Statistics

    The stock is down 11.59% over 52 weeks and trades 11.59% below its 50-day average.

    Beta (1Y)0.71
    52-Week Change-11.59%
    1-Month Change-2.79%
    3-Month Change-4.69%
    6-Month Change-6.87%
    5-Year Change-94.45%
    Total Return (1Y)-11.59%
    Total Return (3Y CAGR)-21.27%
    Total Return (5Y CAGR)-45.09%
    Return vs SPY (1Y)-24.42%
    Max Drawdown (1Y)-41.67%
    Max Drawdown (3Y)-74.29%
    Sharpe Ratio (1Y)-0.20
    Correlation with SPY (1Y)0.14
    50-Day Average$1.38
    200-Day Average$1.31
    52-Week Range$1.02 to $1.91
    RSI (14 Days)44.4
    Average Volume (20 Days)416.49K

    The 5-year change compares month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 9.81x current liabilities, and total debt is 0.00x shareholder equity.

    Current Ratio9.81x
    Quick Ratio9.81x
    Debt / Equity0.00x
    Interest Coverage24.11x

    Returns and Efficiency

    Return on equity is -155.03% over the last 12 months, against a 5-year average of -37.34%.

    Return on Equity (ROE)-155.03%
    Return on Assets (ROA)-79.47%
    ROE (5Y Average)-37.34%
    ROA (5Y Average)-33.86%
    ROIC (5Y Average)-80.09%

    Scores

    PMVP has a Piotroski F-Score of 1 of 9, in the weak band of 0 to 2.

    Piotroski F-Score1 of 9
    Piotroski StrengthWeak

    Income Statement

    Revenue was $0 over the last 12 months.

    Revenue$0
    Gross Profit-$33.00K
    Operating Income-$77.20M
    Pretax Income-$88.51M
    Net Income-$88.53M
    Reported EPS (TTM)-$1.31

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 51.27% of the $111.40M in total assets.

    Cash and Equivalents$19.99M
    Total Debt$0
    Net Cash$19.99M
    Net Cash Per Share$0.30
    Working Capital$94.20M
    Shareholder Equity$57.11M
    Book Value Per Share$0.86
    Total Assets$111.40M
    Total Liabilities$54.30M

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    Operating Cash Flow-$69.63M
    FCF Per Share-$0.92
    Depreciation and Amortization$1.83M

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Growth

    Book Value Per Share Growth (2Y CAGR)-33.07%
    Tangible Book Per Share Growth (2Y CAGR)-33.07%

    Revenue and profit by year

    Dividends and Yields

    PMVP does not pay a dividend.

    Buyback Yield-63.31%
    Shareholder Yield-63.31%

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Frequently Asked Questions About PMVP

    What is PMVP's market cap?

    Pmv Pharmaceuticals has a market cap of $89.89M. Its enterprise value, which adds debt and subtracts cash, is $69.89M.

    How many shares of PMVP are outstanding?

    Pmv Pharmaceuticals has 66.23M shares outstanding. The count is up 24.98% from a year earlier.

    Does PMVP pay a dividend?

    No. Pmv Pharmaceuticals does not pay a dividend.

    How much debt does PMVP have?

    Pmv Pharmaceuticals has $0 of total debt and $19.99M of cash and equivalents, a net cash position of $19.99M.